{"gao_id": "GAO-15-85", "published": "2014-10-10T12:00:00Z", "released": "2014-11-10T07:00:00Z", "summary": "", "title": "Compounded Drugs: Payment Practices Vary across Public Programs and Private Insurers, and Medicare Part B Policy Should Be Clarified", "topics": ["Drug formularies", "Health Care", "Inspection", "Claims processing", "Medicaid", "Policies and procedures", "Outpatient care", "Insurance companies", "Prescription drugs", "Manufacturing industry", "Drug approvals", "Managed health care", "Standards", "Patient care services", "Billing procedures", "Insurance claims", "Payments", "Beneficiaries", "Pharmaceutical industry", "Databases", "Data collection", "Health care programs", "Medicare"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-15-85", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-15-85-highlights.pdf"}, {"title": "Full Report (40 pages)", "url": "https://www.gao.gov/assets/gao-15-85.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/670/666816.txt"}]}